Edwards Lifesciences Corporation — Revenue by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c1232f5-71ff-4445-97fa-444d06cbb255/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $6.1B | 2025-01-01 – 2025-12-31 | evidence 0001099800-26-000009 |
| FY 2024 | $5.4B | 2024-01-01 – 2024-12-31 | evidence 0001099800-25-000005 |
| FY 2023 | $5.0B | 2023-01-01 – 2023-12-31 | evidence 0001099800-25-000005 |
| FY 2022 | $4.5B | 2022-01-01 – 2022-12-31 | evidence 0001099800-25-000005 |
| FY 2021 | $5.2B | 2021-01-01 – 2021-12-31 | evidence 0001099800-22-000005 |
| FY 2020 | $4.4B | 2020-01-01 – 2020-12-31 | evidence 0001099800-21-000007 |
| FY 2019 | $4.3B | 2019-01-01 – 2019-12-31 | evidence 0001099800-20-000005 |
| FY 2018 | $3.7B | 2018-01-01 – 2018-12-31 | evidence 0001099800-19-000004 |
| FY 2017 | $3.4B | 2017-01-01 – 2017-12-31 | evidence 0001099800-19-000004 |
| FY 2016 | $3.0B | 2016-01-01 – 2016-12-31 | evidence 0001099800-19-000004 |
| FY 2015 | $2.5B | 2015-01-01 – 2015-12-31 | evidence 0001099800-16-000044 |
| FY 2014 | $2.3B | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-000998 |
| FY 2013 | $2.0B | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-001583 |
| FY 2012 | $1.9B | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001954 |
| FY 2011 | $1.7B | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001617 |
| FY 2010 | $1.4B | 2010-01-01 – 2010-12-31 | evidence 0001047469-11-001550 |
| FY 2009 | $1.3B | 2009-01-01 – 2009-12-31 | evidence 0001047469-11-001550 |
| FY 2008 | $1.2B | 2008-01-01 – 2008-12-31 | evidence 0001047469-11-001550 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Edwards Lifesciences Corporation — all facts · Net Income · Operating Income